Buprenorphine implants in medical treatment of opioid addiction. Chavoustie S, Frost M, Snyder O, Owen J, Darwish M, Dammerman R, Sanjurjo V. Expert Rev Clin Pharmacol. 2017 Jun 21:1-9. doi: 10.1080/17512433.2017.1336434. Abstract https://www.nc…

Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder. Haasen C, Linden M, Tiberg F. J Subst Abuse Treat. 2017 Jul;78:22-29. doi: 10.1016/j.jsa…

Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial. Ahmadi J, Razeghian Jahromi L. Trials. 2017 Jun 6;18(1):259. doi: 10.1186/s13063-017-2007-3. https://www.ncbi.nlm.nih.go…

USA. With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths By Daniel I. Rees, Joseph J. Sabia, Laura Argys, Joshua Latshaw, & Dhaval Dave Since the early 2000s, the rate of drug ove…

Evidence is growing that two key factors help determine the risks of death in patients being treated for opioid dependence: which medication the patients are—or have been—taking, methadone or buprenorphine; and whether the patients are c…

SAMHSA Buprenorphine Advisory This publication describes the oral-patch forms of buprenorphine approved for opioid treatment, as well as the approved under-the-tongue tablet form, which has been available longer. (SAMHSA – Substance Abuse And…